Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX - Nasdaq - US2270461096 - Common Stock - Currency: USD

108.29  -3.09 (-2.77%)

After market: 108.49 +0.2 (+0.18%)

Fundamental Rating

7

Overall CROX gets a fundamental rating of 7 out of 10. We evaluated CROX against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making CROX a very profitable company, without any liquidiy or solvency issues. CROX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make CROX a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
In the past year CROX had a positive cash flow from operations.
CROX had positive earnings in each of the past 5 years.
In the past 5 years CROX always reported a positive cash flow from operatings.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 18.90%, CROX belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
Looking at the Return On Equity, with a value of 48.63%, CROX belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 21.12%, CROX belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 13.45%.
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROIC 21.12%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

Looking at the Profit Margin, with a value of 23.35%, CROX belongs to the top of the industry, outperforming 97.92% of the companies in the same industry.
CROX's Profit Margin has improved in the last couple of years.
CROX's Operating Margin of 24.84% is amongst the best of the industry. CROX outperforms 95.83% of its industry peers.
CROX's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 59.25%, CROX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CROX is creating value.
The number of shares outstanding for CROX has been reduced compared to 1 year ago.
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.77. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.77, CROX is doing good in the industry, outperforming 68.75% of the companies in the same industry.
CROX has a debt to FCF ratio of 1.68. This is a very positive value and a sign of high solvency as it would only need 1.68 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.68, CROX belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
CROX has a Debt/Equity ratio of 0.75. This is a neutral value indicating CROX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.75, CROX is doing worse than 64.58% of the companies in the same industry.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Altman-Z 3.77
ROIC/WACC2.01
WACC10.49%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.52 indicates that CROX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.52, CROX is doing worse than 68.75% of the companies in the same industry.
CROX has a Quick Ratio of 1.52. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CROX (0.97) is worse than 60.42% of its industry peers.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.97
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.55% over the past year.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.64% on average per year.
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 2.09%.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%

3.2 Future

CROX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.74% yearly.
CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.08% yearly.
EPS Next Y-0.34%
EPS Next 2Y1.63%
EPS Next 3Y0.94%
EPS Next 5Y3.74%
Revenue Next Year2.21%
Revenue Next 2Y2.66%
Revenue Next 3Y2.47%
Revenue Next 5Y3.08%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

CROX is valuated reasonably with a Price/Earnings ratio of 8.25.
CROX's Price/Earnings ratio is rather cheap when compared to the industry. CROX is cheaper than 83.33% of the companies in the same industry.
CROX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.82.
CROX is valuated cheaply with a Price/Forward Earnings ratio of 7.97.
89.58% of the companies in the same industry are more expensive than CROX, based on the Price/Forward Earnings ratio.
CROX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 8.25
Fwd PE 7.97
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CROX indicates a somewhat cheap valuation: CROX is cheaper than 77.08% of the companies listed in the same industry.
83.33% of the companies in the same industry are more expensive than CROX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.87
EV/EBITDA 6.77
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y1.63%
EPS Next 3Y0.94%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (5/23/2025, 9:24:33 PM)

After market: 108.49 +0.2 (+0.18%)

108.29

-3.09 (-2.77%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners100.85%
Inst Owner Change2.17%
Ins Owners2.71%
Ins Owner Change5.04%
Market Cap6.07B
Analysts80.91
Price Target123.98 (14.49%)
Short Float %11.21%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.88%
Min EPS beat(2)9.31%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)12.98%
Min EPS beat(4)9.31%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)14.09%
EPS beat(12)12
Avg EPS beat(12)14.76%
EPS beat(16)16
Avg EPS beat(16)17.35%
Revenue beat(2)2
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0.88%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)1.22%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)7
Avg Revenue beat(12)0.52%
Revenue beat(16)10
Avg Revenue beat(16)1.27%
PT rev (1m)-5.56%
PT rev (3m)-6.52%
EPS NQ rev (1m)1.07%
EPS NQ rev (3m)-0.1%
EPS NY rev (1m)-1.25%
EPS NY rev (3m)-1.09%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)0.69%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 8.25
Fwd PE 7.97
P/S 1.48
P/FCF 6.87
P/OCF 6.37
P/B 3.08
P/tB N/A
EV/EBITDA 6.77
EPS(TTM)13.13
EY12.12%
EPS(NY)13.58
Fwd EY12.54%
FCF(TTM)15.76
FCFY14.56%
OCF(TTM)16.99
OCFY15.69%
SpS73.14
BVpS35.13
TBVpS-9.18
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROCE 23.35%
ROIC 21.12%
ROICexc 21.96%
ROICexgc 53.87%
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
FCFM 21.55%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Debt/EBITDA 1.36
Cap/Depr 95.51%
Cap/Sales 1.68%
Interest Coverage 11.16
Cash Conversion 87.36%
Profit Quality 92.29%
Current Ratio 1.52
Quick Ratio 0.97
Altman-Z 3.77
F-Score6
WACC10.49%
ROIC/WACC2.01
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
EPS Next Y-0.34%
EPS Next 2Y1.63%
EPS Next 3Y0.94%
EPS Next 5Y3.74%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%
Revenue Next Year2.21%
Revenue Next 2Y2.66%
Revenue Next 3Y2.47%
Revenue Next 5Y3.08%
EBIT growth 1Y-4.07%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-0.47%
EBIT Next 3Y-3.04%
EBIT Next 5Y4.44%
FCF growth 1Y53.79%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y39.75%
OCF growth 3Y20.5%
OCF growth 5Y61.62%